Quality by Design–Applied Liquid Chromatography-Tandem Mass Spectrometry Determination of Enzalutamide Anti-Prostate Cancer Therapy Drug in Spiked Plasma Samples

This research article presents the Quality by Design (QbD)–finalised conditions for a method that uses liquid chromatography-tandem mass spectrometry for the determination of concentration of enzalutamide (ENZ), an atypical anticancer drug, in a drug formulation and in spiked plasma samples. Critica...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankar, ASK, Palani, Shanmugasundaram, Velayudham, Ravichandiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576540/
https://www.ncbi.nlm.nih.gov/pubmed/28874884
http://dx.doi.org/10.1177/1177390117726776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576540/
https://www.ncbi.nlm.nih.gov/pubmed/28874884
http://dx.doi.org/10.1177/1177390117726776

Ejemplares similares